Volume 21, Issue 4 (Winter 2024)
Sci J Iran Blood Transfus Organ 2024, 21(4): 296-306 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Chegini A, Jamalian A, maghari A. Cost estimation in hospital blood bank following the implementation of patient blood management. Sci J Iran Blood Transfus Organ 2024; 21 (4) :296-306
URL: http://bloodjournal.ir/article-1-1543-en.html
URL: http://bloodjournal.ir/article-1-1543-en.html
Abstract: (288 Views)
Abstract
Background and Objectives
Excessive blood product transfusions increase morbidity, mortality, and healthcare costs. To address this issue, we investigated the cost savings of implementing patient blood management strategies to reduce unnecessary transfusions.
Materials and Methods
We conducted a cross-sectional study at Shahid Lavasani Hospital from 2016 to 2018, analyzing laboratory service costs in the blood bank before and after adopting patient blood management. Statistical analyses included Friedman repeated measures tests for three-year trends and Wilcoxon signed-rank tests for two-year trends, using SPSS version 21 for comparison.
Results
In 2016, the average cost of red blood cell transfusions was 209336820 rials, which dropped to 185857980 rials in 2017 and 71.2% to 53494250 rials in 2018. The average cost of plasma in 2016, before the establishment of patient blood management, was 95155368 rials. In 2017, this cost decreased by 79.1%, bringing the average down to 19880784 rials. In 2018, it fell further by 57% compared to the previous year, resulting in an average cost of 8537760 rials. Total laboratory service costs decreased by 5.7% from 2015 to 2016 and 53.8% from 2017 to 2018.
Conclusions
Patient blood management reduces costs, making it a financially advantageous strategy for hospitals.
Background and Objectives
Excessive blood product transfusions increase morbidity, mortality, and healthcare costs. To address this issue, we investigated the cost savings of implementing patient blood management strategies to reduce unnecessary transfusions.
Materials and Methods
We conducted a cross-sectional study at Shahid Lavasani Hospital from 2016 to 2018, analyzing laboratory service costs in the blood bank before and after adopting patient blood management. Statistical analyses included Friedman repeated measures tests for three-year trends and Wilcoxon signed-rank tests for two-year trends, using SPSS version 21 for comparison.
Results
In 2016, the average cost of red blood cell transfusions was 209336820 rials, which dropped to 185857980 rials in 2017 and 71.2% to 53494250 rials in 2018. The average cost of plasma in 2016, before the establishment of patient blood management, was 95155368 rials. In 2017, this cost decreased by 79.1%, bringing the average down to 19880784 rials. In 2018, it fell further by 57% compared to the previous year, resulting in an average cost of 8537760 rials. Total laboratory service costs decreased by 5.7% from 2015 to 2016 and 53.8% from 2017 to 2018.
Conclusions
Patient blood management reduces costs, making it a financially advantageous strategy for hospitals.
References
1. WHO. Availability, safety, and quality of blood products. Sixty-third World Health Assembly; 2010. Available from: https://apps.who.int/gb/ebwha/pdf_files/wha63/a63_r12-en.pdf.
2. Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017; 57(6): 1347-58. [DOI:10.1111/trf.14006] [PMID]
3. Verdecchia NM, Wisniewski MK, Waters JH, Triulzi DJ, Alarcon LH, Yazer MH. Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: a 9-year follow-up. Hematology 2016; 21(8): 490-9 [DOI:10.1080/10245332.2015.1112496] [PMID]
4. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50(4): 753-65. [DOI:10.1111/j.1537-2995.2009.02518.x] [PMID]
5. Shander, A. Transfusion Overuse Exposing an International Problem and Patient Safety Issue. Available online: https://www.sabm.org/assets/pdfs/SABM-Transfusion-Overuse-2019.pd
6. Drabinski T, Zacharowski K, Meybohm P, Ruger AM, de Arellano AR. Estimating the epidemiological and economic impact of implementing preoperative anaemia measures in the German healthcare system: the health economic footprint of patient blood management. Adv Ther 2020; 37(8): 3515-36. [DOI:10.1007/s12325-020-01372-4] [PMID] []
7. Jadwin DF, Fenderson PG, Friedman MT, Jenkins I, Shander A, Waters JH, et al. Determination of unnecessary blood transfusion by comprehensive 15-hospital record review. Jt Comm J Qual Patient Saf 2023; 49(1): 42-52. [DOI:10.1016/j.jcjq.2022.10.006] [PMID]
8. Freedman J, Luke K, Escobar M, Vernch L, Chiavetta JA. Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators[ONTraC]). Transfusion 2008; 48: 237-50.19. [DOI:10.1111/j.1537-2995.2007.01515.x] [PMID]
9. Meybohm P, Herrmann E, Steinbicker AU, Wittmann M, Gruenewald M, Fischer D, et al. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient'soutcome: a prospective, multicenter cohort study with anoninferiority design. Ann Surg 2016; 264: 203-11. [DOI:10.1097/SLA.0000000000001747] [PMID]
10. LaPar DJ, Crosby IK, Ailawadi G, Ad N, Choi E, Spiess BD, et al. Blood product conser-vation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg 2013; 145: 796-803. [DOI:10.1016/j.jtcvs.2012.12.041] [PMID]
11. Farmer SL, Towler SC, Leahy MF, Hofmann A. Drivers forchange: Western Australia Patient Blood Management Pro-gram (WA PBMP), World Health Assembly (WHA) and Advi-sory Committee on Blood Safety and Availability (ACBSA). Best Pract Res Clin Anaesthesiol 2013; 27(1): 43-58. [DOI:10.1016/j.bpa.2012.12.007] [PMID]
12. Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costsassociated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017; 57: 1347-58 [DOI:10.1111/trf.14006] [PMID]
13. Wu DW, Friedman MT, Lombardi DP, Hwang R, Sender J, Cobaj V, et al. Impact of Patient Blood Management on Red Blood Cell Utilization in an Urban Community Teaching Hospital: A Seven-Year Retrospective Study. Life 2024; 14(2): 232. [DOI:10.3390/life14020232] [PMID] []
14. Duarte GD, Fujita Neto FG, Marques Júnior JF, Langhi DM. Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system. Hematol Transfus Cell Ther 2022; 44: 374-8. [DOI:10.1016/j.htct.2020.12.010] [PMID] []
15. Meybohm P, Straub N, Füllenbach C, Judd L, Kleinerüschkamp A, Taeuber I, et al. Health economics of Patient Blood Management: a cost‐benefit analysis based on a meta‐analysis. Vox Sang 2020; 115(2): 182-8. [DOI:10.1111/vox.12873] [PMID]
16. Calvet X, Gené E, ÀngelRuíz M, Figuerola A, Villoria A, Cucala M, et al. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. Technol Health Care 2016; 24: 111-20 [DOI:10.3233/THC-151074] [PMID]
17. Froessler B, Rueger AM, Connolly MP. Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany. Risk Manag Healthc Policy 2018; 11: 77-82. [DOI:10.2147/RMHP.S157379] [PMID] []
18. Wu DW, Friedman MT, Lombardi DP, Hwang R, Sender J, Cobaj V, et al. Impact of Patient Blood Management on Red Blood Cell Utilization in an Urban Community Teaching Hospital: A Seven-Year Retrospective Study. Life 2024; 14(2): 232. [DOI:10.3390/life14020232] [PMID] []
19. Warner MA, Schulte PJ, Hanson AC, Madde NR, Burt JM, Higgins AA, et al. Implementation of a Comprehensive Patient Blood Management Program for Hospitalized Patients at a Large United States Medical Center. Mayo Clin Proc 2021; 96: 2980-90. [DOI:10.1016/j.mayocp.2021.07.017] [PMID] []
20. Hofmann A, Shander A, Blumberg N, Hamdorf JM, Isbister JP, Gross I. Patient blood management: improving outcomes for millions while saving billions. what is holding it up? Anesth Analg 2022; 135(3): 511-23. [DOI:10.1213/ANE.0000000000006138] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
